All Articles

A growing body of research has demonstrated that 5 to 10 years of adjuvant endocrine therapy (ET) plus ovarian function suppression (OFS) in patients with estrogen receptor (ER)-positive breast cancer reduces disease recurrence and mortality. However, despite this proven benefit, adverse events (AEs) associated with ET plus OFS may have a negative impact on patients’ quality of life.

In addition to the consideration of patient age, treatment selection for advanced breast cancer should include consideration of disease characteristics as outlined in evidence-based guidelines.

The Young Survival Coalition (YSC) is a nonprofit patient advocacy organization in the United States that supports approximately 250,000 patients diagnosed with breast cancer before the age of 40 years.

Navigators remove barriers to care and improve health disparities, but if navigation models aren’t sustainable, patients lose, and health inequities persist.

As of January 1, 2024, coding, billing, and payment for principal illness navigation services is a reality that marks a new era for oncology patient navigation.

African American culture, the importance of the patient voice, and story sharing are just some of the themes that emerged from a study to understand the work of African American breast cancer advocates.

Navigators have 2 key roles related to the important work of improving diversity in clinical trials.